These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37024668)

  • 1. Deep learning-based polygenic risk analysis for Alzheimer's disease prediction.
    Zhou X; Chen Y; Ip FCF; Jiang Y; Cao H; Lv G; Zhong H; Chen J; Ye T; Chen Y; Zhang Y; Ma S; Lo RMN; Tong EPS; ; Mok VCT; Kwok TCY; Guo Q; Mok KY; Shoai M; Hardy J; Chen L; Fu AKY; Ip NY
    Commun Med (Lond); 2023 Apr; 3(1):49. PubMed ID: 37024668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes.
    Gunter NB; Gebre RK; Graff-Radford J; Heckman MG; Jack CR; Lowe VJ; Knopman DS; Petersen RC; Ross OA; Vemuri P; Ramanan VK;
    Neurol Genet; 2024 Feb; 10(1):e200120. PubMed ID: 38250184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of medical domain knowledge on deep learning for Alzheimer's disease prediction.
    Ljubic B; Roychoudhury S; Cao XH; Pavlovski M; Obradovic S; Nair R; Glass L; Obradovic Z
    Comput Methods Programs Biomed; 2020 Dec; 197():105765. PubMed ID: 33011665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
    Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population.
    Zhou X; Chen Y; Ip FCF; Lai NCH; Li YYT; Jiang Y; Zhong H; Chen Y; Zhang Y; Ma S; Lo RMN; Cheung K; Tong EPS; Ko H; Shoai M; Mok KY; Hardy J; Mok VCT; Kwok TCY; Fu AKY; Ip NY
    Alzheimers Dement (Amst); 2020; 12(1):e12074. PubMed ID: 32775599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRPa-PRS: A risk stratification method to identify genetically-regulated pathways in polygenic diseases.
    Li X; Fernandes BS; Liu A; Chen J; Chen X; Zhao Z; Dai Y
    medRxiv; 2024 Jul; ():. PubMed ID: 37425929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
    Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk and hazard scores for Alzheimer's disease prediction.
    Leonenko G; Sims R; Shoai M; Frizzati A; Bossù P; Spalletta G; Fox NC; Williams J; ; Hardy J; Escott-Price V
    Ann Clin Transl Neurol; 2019 Mar; 6(3):456-465. PubMed ID: 30911569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prediction of Alzheimer's disease through multi-trait genetic modeling.
    Clark K; Fu W; Liu CL; Ho PC; Wang H; Lee WP; Chou SY; Wang LS; Tzeng JY
    Front Aging Neurosci; 2023; 15():1168638. PubMed ID: 37577355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Convolutional Neural Networks and Multi-Task Dictionary Learning for Cognitive Decline Prediction with Longitudinal Images.
    Dong Q; Zhang J; Li Q; Wang J; Leporé N; Thompson PM; Caselli RJ; Ye J; Wang Y;
    J Alzheimers Dis; 2020; 75(3):971-992. PubMed ID: 32390615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network.
    Liang W; Zhang K; Cao P; Liu X; Yang J; Zaiane O
    Comput Biol Med; 2021 Nov; 138():104935. PubMed ID: 34656869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
    Jemimah S; AlShehhi A;
    BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-Deep Learning Based Automatic Diagnosis of Alzheimer's Disease with Joint MMSE Prediction Using Resting-State fMRI.
    Duc NT; Ryu S; Qureshi MNI; Choi M; Lee KH; Lee B
    Neuroinformatics; 2020 Jan; 18(1):71-86. PubMed ID: 31093956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Detection of Alzheimer's Disease Using Magnetic Resonance Imaging: A Novel Approach Combining Convolutional Neural Networks and Ensemble Learning.
    Pan D; Zeng A; Jia L; Huang Y; Frizzell T; Song X
    Front Neurosci; 2020; 14():259. PubMed ID: 32477040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
    Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
    Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensemble of convolutional neural networks and multilayer perceptron for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Li M; Jiang Y; Li X; Yin S; Luo H
    Med Phys; 2023 Jan; 50(1):209-225. PubMed ID: 36121183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
    Hermes S; Cady J; Armentrout S; O'Connor J; Holdaway SC; Cruchaga C; Wingo T; Greytak EM;
    J Alzheimers Dis; 2024; 99(4):1425-1440. PubMed ID: 38788065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.